Literature DB >> 28475924

Characterization of Zika virus binding and enhancement potential of a large panel of flavivirus murine monoclonal antibodies.

Elinor Willis1, Scott E Hensley2.   

Abstract

Zika viruses (ZIKVs) are circulating in parts of the world endemic for other flavivirus infections. Some cross-reactive antibodies (Abs) elicited by prior flavivirus exposures can bind to ZIKV and enhance infection of Fc receptor-bearing cells. Here, we measured ZIKV binding of 54 murine monoclonal Abs (mAbs) elicited by exposure with Dengue virus and West Nile virus antigens. We found that 8 of 54 mAbs recognized the envelope protein of ZIKV in conventional binding assays. These 8 cross-reactive mAbs have different specificities; most recognize the DI/II region of the envelope protein but one mAb recognized the DIII lateral ridge of the envelope protein. Interestingly, only 3 of these cross-reactive mAbs were able to enhance ZIKV infection in vitro, and enhancing potential was not strictly correlated with relative binding ability. These data suggest that the ability of flavivirus Abs to enhance ZIKV is dependent on multiple factors.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibody; Antibody mediated enhancement; Flavivirus; Zika virus

Mesh:

Substances:

Year:  2017        PMID: 28475924      PMCID: PMC5539878          DOI: 10.1016/j.virol.2017.04.031

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  43 in total

1.  Zika virus. I. Isolations and serological specificity.

Authors:  G W A DICK; S F KITCHEN; A J HADDOW
Journal:  Trans R Soc Trop Med Hyg       Date:  1952-09       Impact factor: 2.184

Review 2.  Prospects for a dengue virus vaccine.

Authors:  Stephen S Whitehead; Joseph E Blaney; Anna P Durbin; Brian R Murphy
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

3.  Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection.

Authors:  Karin Stettler; Martina Beltramello; Diego A Espinosa; Victoria Graham; Antonino Cassotta; Siro Bianchi; Fabrizia Vanzetta; Andrea Minola; Stefano Jaconi; Federico Mele; Mathilde Foglierini; Mattia Pedotti; Luca Simonelli; Stuart Dowall; Barry Atkinson; Elena Percivalle; Cameron P Simmons; Luca Varani; Johannes Blum; Fausto Baldanti; Elisabetta Cameroni; Roger Hewson; Eva Harris; Antonio Lanzavecchia; Federica Sallusto; Davide Corti
Journal:  Science       Date:  2016-07-14       Impact factor: 47.728

4.  Computed Tomographic Findings in Microcephaly Associated with Zika Virus.

Authors:  Adriano N Hazin; Andrea Poretti; Danielle Di Cavalcanti Souza Cruz; Marli Tenorio; Ana van der Linden; Lindomar Jose Pena; Carlos Brito; Laura H Vega Gil; Demócrito de Barros Miranda-Filho; Ernesto Torres de Azevedo Marques; Celina M Turchi Martelli; João G Bezerra Alves; Thierry A Huisman
Journal:  N Engl J Med       Date:  2016-04-06       Impact factor: 91.245

5.  Antibody-enhanced dengue virus infection in primate leukocytes.

Authors:  S B Halstead; E J O'Rourke
Journal:  Nature       Date:  1977-02-24       Impact factor: 49.962

6.  The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.

Authors:  Bimmi Shrestha; James D Brien; Soila Sukupolvi-Petty; S Kyle Austin; Melissa A Edeling; Taekyung Kim; Katie M O'Brien; Christopher A Nelson; Syd Johnson; Daved H Fremont; Michael S Diamond
Journal:  PLoS Pathog       Date:  2010-04-01       Impact factor: 6.823

7.  Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence.

Authors:  E A Henchal; M K Gentry; J M McCown; W E Brandt
Journal:  Am J Trop Med Hyg       Date:  1982-07       Impact factor: 2.345

8.  Zika Virus Infection in Pregnant Women in Rio de Janeiro.

Authors:  Patrícia Brasil; José P Pereira; M Elisabeth Moreira; Rita M Ribeiro Nogueira; Luana Damasceno; Mayumi Wakimoto; Renata S Rabello; Stephanie G Valderramos; Umme-Aiman Halai; Tania S Salles; Andrea A Zin; Dafne Horovitz; Pedro Daltro; Marcia Boechat; Claudia Raja Gabaglia; Patrícia Carvalho de Sequeira; José H Pilotto; Raquel Medialdea-Carrera; Denise Cotrim da Cunha; Liege M Abreu de Carvalho; Marcos Pone; André Machado Siqueira; Guilherme A Calvet; Ana E Rodrigues Baião; Elizabeth S Neves; Paulo R Nassar de Carvalho; Renata H Hasue; Peter B Marschik; Christa Einspieler; Carla Janzen; James D Cherry; Ana M Bispo de Filippis; Karin Nielsen-Saines
Journal:  N Engl J Med       Date:  2016-03-04       Impact factor: 91.245

9.  Zika virus infection complicated by Guillain-Barre syndrome--case report, French Polynesia, December 2013.

Authors:  E Oehler; L Watrin; P Larre; I Leparc-Goffart; S Lastere; F Valour; L Baudouin; Hp Mallet; D Musso; F Ghawche
Journal:  Euro Surveill       Date:  2014-03-06

Review 10.  Dendritic cells in dengue virus infection: targets of virus replication and mediators of immunity.

Authors:  Michael A Schmid; Michael S Diamond; Eva Harris
Journal:  Front Immunol       Date:  2014-12-17       Impact factor: 7.561

View more
  12 in total

1.  Dengue Virus Immunity Increases Zika Virus-Induced Damage during Pregnancy.

Authors:  Julia A Brown; Gursewak Singh; Joshua A Acklin; Silviana Lee; James E Duehr; Anupa N Chokola; Justin J Frere; Kevin W Hoffman; Gregory A Foster; David Krysztof; Richard Cadagan; Adam R Jacobs; Susan L Stramer; Florian Krammer; Adolfo García-Sastre; Jean K Lim
Journal:  Immunity       Date:  2019-02-05       Impact factor: 31.745

2.  Human Monoclonal Antibodies Potently Neutralize Zika Virus and Select for Escape Mutations on the Lateral Ridge of the Envelope Protein.

Authors:  Mark J Bailey; Felix Broecker; Alec W Freyn; Angela Choi; Julia A Brown; Nadia Fedorova; Viviana Simon; Jean K Lim; Matthew J Evans; Adolfo García-Sastre; Peter Palese; Gene S Tan
Journal:  J Virol       Date:  2019-06-28       Impact factor: 5.103

3.  Recombinant Zika Virus Subunits Are Immunogenic and Efficacious in Mice.

Authors:  Albert To; Liana O Medina; Kenji O Mfuh; Michael M Lieberman; Teri Ann S Wong; Madhuri Namekar; Eileen Nakano; Chih-Yun Lai; Mukesh Kumar; Vivek R Nerurkar; Axel T Lehrer
Journal:  mSphere       Date:  2018-01-10       Impact factor: 4.389

4.  Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge.

Authors:  Jinsheng Wen; Annie Elong Ngono; Jose Angel Regla-Nava; Kenneth Kim; Matthew J Gorman; Michael S Diamond; Sujan Shresta
Journal:  Nat Commun       Date:  2017-11-13       Impact factor: 14.919

5.  Tick-Borne Encephalitis Virus Vaccine-Induced Human Antibodies Mediate Negligible Enhancement of Zika Virus Infection InVitro and in a Mouse Model.

Authors:  James Duehr; Silviana Lee; Gursewak Singh; Gregory A Foster; David Krysztof; Susan L Stramer; Maria C Bermúdez González; Eva Menichetti; Robert Geretschläger; Christian Gabriel; Viviana Simon; Jean K Lim; Florian Krammer
Journal:  mSphere       Date:  2018-02-07       Impact factor: 4.389

6.  Critical neutralizing fragment of Zika virus EDIII elicits cross-neutralization and protection against divergent Zika viruses.

Authors:  Wanbo Tai; Lei He; Yufei Wang; Shihun Sun; Guangyu Zhao; Chuming Luo; Pei Li; Haiyan Zhao; Daved H Fremont; Fang Li; Shibo Jiang; Yusen Zhou; Lanying Du
Journal:  Emerg Microbes Infect       Date:  2018-01-24       Impact factor: 7.163

7.  Evaluating the Safety of West Nile Virus Immunity During Congenital Zika Virus Infection in Mice.

Authors:  Joshua A Acklin; Javier D Cattle; Arianna S Moss; Julia A Brown; Gregory A Foster; David Krysztof; Susan L Stramer; Jean K Lim
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561

Review 8.  Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.

Authors:  Rekha Khandia; Ashok Munjal; Kuldeep Dhama; Kumaragurubaran Karthik; Ruchi Tiwari; Yashpal Singh Malik; Raj Kumar Singh; Wanpen Chaicumpa
Journal:  Front Immunol       Date:  2018-04-23       Impact factor: 7.561

9.  Antigenicity, stability, and reproducibility of Zika reporter virus particles for long-term applications.

Authors:  J Charles Whitbeck; Anu Thomas; Kathryn Kadash-Edmondson; Ariadna Grinyo-Escuer; Lewis J Stafford; Celine Cheng; Grant C Liao; Frederick W Holtsberg; M Javad Aman; Graham Simmons; Edgar Davidson; Benjamin J Doranz
Journal:  PLoS Negl Trop Dis       Date:  2020-11-18

10.  Zika Virus-Like Particles Bearing a Covalent Dimer of Envelope Protein Protect Mice from Lethal Challenge.

Authors:  Giuditta De Lorenzo; Rapeepat Tandavanitj; Jennifer Doig; Chayanee Setthapramote; Monica Poggianella; Ricardo Sanchez-Velazquez; Hannah E Scales; Julia M Edgar; Alain Kohl; James Brewer; Oscar R Burrone; Arvind H Patel
Journal:  J Virol       Date:  2020-12-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.